ICD-10 code D75.839 for Thrombocytosis, unspecified is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism . Subscribe to Codify and get the code details in a flash.
2018/2019 ICD-10-CM Diagnosis Code I82.401. Acute embolism and thrombosis of unspecified deep veins of right lower extremity. 2016 2017 2018 2019 Billable/Specific Code.
L03.115 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM L03.115 became effective on October 1, 2020. This is the American ICD-10-CM version of L03.115 - other international versions of ICD-10 L03.115 may differ. viral warts ( B07.-) viral warts ( B07.-)
Unspecified lump in the right breast, unspecified quadrant. N63.10 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM N63.10 became effective on October 1, 2020.
I45.10ICD-10 Code for Unspecified right bundle-branch block- I45. 10- Codify by AAPC.
Essential (hemorrhagic) thrombocythemia D47. 3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D47. 3 became effective on October 1, 2021.
839.
reactive thrombocytosis (D75.838)secondary thrombocytosis (D75.838)thrombocythemia NOS (D75.839)thrombocytosis NOS (D75.839)
Thrombocythemia refers to a high platelet count that is not caused by another health condition. This condition is sometimes called primary or essential thrombocythemia. Thrombocytosis refers to a high platelet count caused by another disease or condition.
Other secondary thrombocytopenia D69. 59 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D69. 59 became effective on October 1, 2021.
Essential thrombocythemia may be caused by a person acquiring (not inheriting) a somatic genetic change in any of several genes, such as the JAK2 gene (most frequently), CALR gene, and rarely, the MPL, THPO, or TET2 gene. The reason why some people acquire genetic changes that cause the disease is unknown.
SymptomsHeadache.Dizziness or lightheadedness.Chest pain.Weakness.Numbness or tingling of the hands and feet.
Thrombocythemia is when the cause of a high platelet count isn't known. The condition sometimes is called primary or essential thrombocythemia. Thrombocytosis or thrombocythemia by themselves are not reportable.
Primary thrombocytosis is a myeloproliferative disease, caused by monoclonal or polyclonal abnormalities of haematopoietic cells or by abnormalities in the biology of Tpo. Secondary thrombocytosis is caused by stimulated megakaryopoiesis because of various haematological or non-haematological disorders.
Essential thrombocythemia is a chronic disease with no cure. If you have a mild form of the disease, you may not need treatment. If you have severe symptoms, you may need medicine that lowers your platelet count, blood thinners or both.
Even though the platelet count is elevated for a short time (or even indefinitely after splenectomy), secondary thrombocytosis does not typically lead to abnormal blood clotting. Primary thrombocytosis, or essential thrombocythemia, can cause serious bleeding or clotting complications.